AAAAAA

   
Results: 1-11 |
Results: 11
Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure
Authors: Keller, C Nanda, R Shannon, RL Amit, A Kaplan, AL
Citation: C. Keller et al., Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure, INT J GYN C, 11(3), 2001, pp. 247-250
Primary choriocarcinoma of the vulva
Authors: Weiss, S Amit, A Schwartz, MR Kaplan, AL
Citation: S. Weiss et al., Primary choriocarcinoma of the vulva, INT J GYN C, 11(3), 2001, pp. 251-254
Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV
Authors: Amit, A Edwards, CL Athey, P Kaplan, AL
Citation: A. Amit et al., Extensive subcutaneous metastases from squamous cell carcinoma of the cervix in patient with HIV, INT J GYN C, 11(1), 2001, pp. 78-80
Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study - Response
Authors: Newby, LK Kaplan, AL Tuttle, RH McNulty, SE Ohman, EM Storrow, AB Gibler, WB
Citation: Lk. Newby et al., Bedside multimarker testing for risk stratification in chest pain units: The chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study - Response, CIRCULATION, 104(22), 2001, pp. E125-E126
Bedside multimarker testing for risk stratification in chest pain units - The chest pain evaluation by creatine Kinase-MB, myoglobin, and troponin I (CHECKMATE) study
Authors: Newby, LK Storrow, AB Gibler, WB Garvey, JL Tucker, JF Kaplan, AL Schreiber, DH Tuttle, RH McNulty, SE Ohman, M
Citation: Lk. Newby et al., Bedside multimarker testing for risk stratification in chest pain units - The chest pain evaluation by creatine Kinase-MB, myoglobin, and troponin I (CHECKMATE) study, CIRCULATION, 103(14), 2001, pp. 1832-1837
Effectiveness and safety of Abciximab after failed thrombolytic therapy
Authors: Cantor, WJ Kaplan, AL Velianou, JL Sketch, MH Barsness, GW Berger, PB Ohman, EM
Citation: Wj. Cantor et al., Effectiveness and safety of Abciximab after failed thrombolytic therapy, AM J CARD, 87(4), 2001, pp. 439
Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit
Authors: Newby, LK Kaplan, AL Granger, BB Sedor, F Califf, RM Ohman, EM
Citation: Lk. Newby et al., Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit, AM J CARD, 85(7), 2000, pp. 801-805
Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim
Authors: Friedman, LC Webb, JA Richards, CS Lynch, GR Kaplan, AL Brunicardi, FC Plon, SE
Citation: Lc. Friedman et al., Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim, GENET MED, 1(3), 1999, pp. 74-79
Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: An emerging solution for reperfusion
Authors: Kaplan, AL Goldmann, B Ohman, EM
Citation: Al. Kaplan et al., Combination fibrinolytic therapy and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction: An emerging solution for reperfusion, J EMERG MED, 17(3), 1999, pp. 589-595
Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment
Authors: Hasenburg, A Tong, XW Rojas-Martinez, A Nyberg-Hoffman, C Kieback, CC Kaplan, AL Kaufman, RH Ramzy, I Aguilar-Cordova, E Kieback, DG
Citation: A. Hasenburg et al., Thymidine kinase (TK) gene therapy of solid tumors: Valacyclovir facilitates outpatient treatment, ANTICANC R, 19(3B), 1999, pp. 2163-2165
Cardiac markers: point of care testing
Authors: Hudson, MP Christenson, RH Newby, LK Kaplan, AL Ohman, EM
Citation: Mp. Hudson et al., Cardiac markers: point of care testing, CLIN CHIM A, 284(2), 1999, pp. 223-237
Risultati: 1-11 |